Diclomezin
CAS: 62865-36-5
Ref. 3D-MCA86536
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
- 3(2H)-Pyridazinone, 6-(3,5-dichloro-4-methylphenyl)-
- 6-(3,5-dichloro-4-methylphenyl)-3(2H)-pyridazinone
- 6-(3,5-dichloro-4-methylphenyl)pyridazin-3(2H)-one
- Monguard
Diclomezin is a medicinal analog that has been shown to inhibit the activity of tumor kinases in human cancer cells. It acts as an inhibitor of protein kinases, leading to apoptosis or programmed cell death in cancer cells. Diclomezin has been found to be effective against various types of cancers, including lung and breast cancers. This anticancer drug has also been shown to have a favorable safety profile, with no significant side effects reported in clinical trials. Diclomezin is excreted through urine and has been extensively studied as a potential therapeutic agent for cancer treatment. This inhibitor may have promising applications in the development of novel therapies for Chinese patients suffering from cancer.
Chemical properties
Technical inquiry about: 3D-MCA86536 Diclomezin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
